Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label,Multi-Center, Follow-Up Study Designed to Evaluate the Long-Term Effects of AP-CD/LD in Fluctuating Parkinson's Disease Subjects Who Completed Study IN 11 004

NCT02615873 is registered in ClinicalTrials.gov with Intec Pharma Ltd. as lead sponsor.

NCT NCT02615873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02615873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label,Multi-Center, Follow-Up Study Designed to Evaluate the Long-Term Effects of AP-CD/LD in Fluctuating Parkinson's Disease Subjects Who Completed Study IN 11 004
Lead sponsor
Intec Pharma Ltd.
Phase
Phase 3
Overall status
Unknown status
Start date
July 31, 2016
Completion date
December 31, 2019
Enrollment
460 (estimated)
Sites
85

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease